Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors
- 21 January 2003
- journal article
- letter
- Published by Springer Science and Business Media LLC in Nature Genetics
- Vol. 33 (2), 197-202
- https://doi.org/10.1038/ng1077
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Identification in the Human Candidate Tumor Suppressor GeneHIC-1 of a New Major Alternative TATA-less Promoter Positively Regulated by p53Published by Elsevier BV ,2001
- The age of cancerNature, 2000
- Mice deficient in the candidate tumor suppressor gene Hic1 exhibit developmental defects of structures affected in the Miller-Dieker syndromeHuman Molecular Genetics, 2000
- Mouse Models of Tumor Development in Neurofibromatosis Type 1Science, 1999
- DNA hypermethylation at the D17S5 locus and reducedHIC-1mRNA expression are associated with hepatocarcinogenesisHepatology, 1999
- Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formationThe EMBO Journal, 1998
- Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancerOncogene, 1998
- Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.Proceedings of the National Academy of Sciences of the United States of America, 1996
- p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3Nature Medicine, 1995
- The POZ domain: a conserved protein-protein interaction motif.Genes & Development, 1994